We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Stay Ahead of the Game With Leidos (LDOS) Q2 Earnings: Wall Street's Insights on Key Metrics
Read MoreHide Full Article
Analysts on Wall Street project that Leidos (LDOS - Free Report) will announce quarterly earnings of $2.63 per share in its forthcoming report, representing no change year over year. Revenues are projected to reach $4.23 billion, increasing 2.4% from the same quarter last year.
The current level reflects a downward revision of 0.8% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.
With that in mind, let's delve into the average projections of some Leidos metrics that are commonly tracked and projected by analysts on Wall Street.
The consensus among analysts is that 'Revenues- Health & Civil' will reach $1.28 billion. The estimate suggests a change of +1.5% year over year.
Analysts predict that the 'Revenues- National Security and Digital' will reach $1.86 billion. The estimate suggests a change of +2.4% year over year.
The consensus estimate for 'Revenues- Commercial & International' stands at $584.26 million. The estimate suggests a change of +4.2% year over year.
The average prediction of analysts places 'Revenues- Defense Systems' at $514.06 million. The estimate indicates a change of +3.9% from the prior-year quarter.
The combined assessment of analysts suggests that 'Non-GAAP operating income (loss)- Defense Systems' will likely reach $45.61 million. Compared to the present estimate, the company reported $51.00 million in the same quarter last year.
According to the collective judgment of analysts, 'Non-GAAP operating income (loss)- Health & Civil' should come in at $270.25 million. The estimate is in contrast to the year-ago figure of $314.00 million.
It is projected by analysts that the 'Non-GAAP operating income (loss)- National Security and Digital' will reach $185.47 million. Compared to the current estimate, the company reported $188.00 million in the same quarter of the previous year.
Based on the collective assessment of analysts, 'Non-GAAP operating income (loss)- Commercial & International' should arrive at $47.82 million. Compared to the current estimate, the company reported $4.00 million in the same quarter of the previous year.
Over the past month, shares of Leidos have returned -1% versus the Zacks S&P 500 composite's +2.7% change. Currently, LDOS carries a Zacks Rank #2 (Buy), suggesting that it may outperform. the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Stay Ahead of the Game With Leidos (LDOS) Q2 Earnings: Wall Street's Insights on Key Metrics
Analysts on Wall Street project that Leidos (LDOS - Free Report) will announce quarterly earnings of $2.63 per share in its forthcoming report, representing no change year over year. Revenues are projected to reach $4.23 billion, increasing 2.4% from the same quarter last year.
The current level reflects a downward revision of 0.8% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.
With that in mind, let's delve into the average projections of some Leidos metrics that are commonly tracked and projected by analysts on Wall Street.
The consensus among analysts is that 'Revenues- Health & Civil' will reach $1.28 billion. The estimate suggests a change of +1.5% year over year.
Analysts predict that the 'Revenues- National Security and Digital' will reach $1.86 billion. The estimate suggests a change of +2.4% year over year.
The consensus estimate for 'Revenues- Commercial & International' stands at $584.26 million. The estimate suggests a change of +4.2% year over year.
The average prediction of analysts places 'Revenues- Defense Systems' at $514.06 million. The estimate indicates a change of +3.9% from the prior-year quarter.
The combined assessment of analysts suggests that 'Non-GAAP operating income (loss)- Defense Systems' will likely reach $45.61 million. Compared to the present estimate, the company reported $51.00 million in the same quarter last year.
According to the collective judgment of analysts, 'Non-GAAP operating income (loss)- Health & Civil' should come in at $270.25 million. The estimate is in contrast to the year-ago figure of $314.00 million.
It is projected by analysts that the 'Non-GAAP operating income (loss)- National Security and Digital' will reach $185.47 million. Compared to the current estimate, the company reported $188.00 million in the same quarter of the previous year.
Based on the collective assessment of analysts, 'Non-GAAP operating income (loss)- Commercial & International' should arrive at $47.82 million. Compared to the current estimate, the company reported $4.00 million in the same quarter of the previous year.
View all Key Company Metrics for Leidos here>>>Over the past month, shares of Leidos have returned -1% versus the Zacks S&P 500 composite's +2.7% change. Currently, LDOS carries a Zacks Rank #2 (Buy), suggesting that it may outperform. the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .